Van Eck Associates Corp Bio N Tech Se Transaction History

Van Eck Associates Corp

$80.1 Billion
Q3 2024

A detailed history of Van Eck Associates Corp transactions in Bio N Tech Se stock. As of the latest transaction made, Van Eck Associates Corp holds 94,685 shares of BNTX stock, worth $11.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

94,685

Previous 119,901 21.03%

Holding current value

$11.6 Million

Previous $9.64 Million 9.07%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$78.36 - $124.66 $1.98 Million - $3.14 Million	-25,216 Reduced 21.03%	94,685 $10.5 Million
Q2 2024 Jul 31, 2024	BUY	$80.36 - $102.87 $176,149 - $225,491	2,192 Added 1.86%	119,901 $9.64 Million
Q1 2024 Apr 30, 2024	BUY	$88.96 - $112.35 $801,796 - $1.01 Million	9,013 Added 8.29%	117,709 $10.9 Million
Q4 2023 Feb 05, 2024	SELL	$90.91 - $112.75 $1.57 Million - $1.95 Million	-17,318 Reduced 13.74%	108,696 $11.5 Million
Q3 2023 Nov 08, 2023	SELL	$98.5 - $125.08 $590,310 - $749,604	-5,993 Reduced 4.54%	126,014 $13.7 Million
Q2 2023 Aug 03, 2023	SELL	$102.58 - $129.66 $475,868 - $601,492	-4,639 Reduced 3.39%	132,007 $14.2 Million
Q1 2023 May 03, 2023	SELL	$122.57 - $153.67 $1.6 Million - $2 Million	-13,030 Reduced 8.71%	136,646 $17 Million
Q4 2022 Feb 08, 2023	BUY	$118.43 - $186.05 $3.05 Million - $4.78 Million	25,715 Added 20.74%	149,676 $22.5 Million
Q3 2022 Oct 27, 2022	SELL	$127.65 - $183.11 $1.42 Million - $2.04 Million	-11,137 Reduced 8.24%	123,961 $16.7 Million
Q2 2022 Aug 03, 2022	SELL	$123.25 - $186.24 $989,574 - $1.5 Million	-8,029 Reduced 5.61%	135,098 $20.1 Million
Q1 2022 May 10, 2022	BUY	$126.25 - $231.85 $6.49 Million - $11.9 Million	51,437 Added 56.1%	143,127 $24.4 Million
Q4 2021 Jan 26, 2022	BUY	$216.64 - $362.52 $827,564 - $1.38 Million	3,820 Added 4.35%	91,690 $23.6 Million
Q3 2021 Nov 03, 2021	SELL	$205.93 - $447.23 $3.4 Million - $7.39 Million	-16,533 Reduced 15.84%	87,870 $24 Million
Q2 2021 Aug 10, 2021	SELL	$113.32 - $241.49 $3.09 Million - $6.59 Million	-27,288 Reduced 20.72%	104,403 $23.4 Million
Q1 2021 May 13, 2021	SELL	$85.73 - $119.5 $2.12 Million - $2.96 Million	-24,763 Reduced 15.83%	131,691 $14.4 Million
Q4 2020 Feb 09, 2021	BUY	$72.71 - $129.54 $3.27 Million - $5.83 Million	44,986 Added 40.36%	156,454 $12.8 Million
Q3 2020 Nov 12, 2020	BUY	$57.81 - $104.17 $6.44 Million - $11.6 Million	111,468 New	111,468 $7.72 Million

Others Institutions Holding BNTX

# of Institutions

356

Shares Held

38.3M

Call Options Held

2.45M

Put Options Held

2.29M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $29.8B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Account

Van Eck Associates Corp Bio N Tech Se Transaction History